Cargando…
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer
The treatment provided for breast cancer depends on the expression of hormone receptors, human epidermal growth factor receptor-2 (HER2), and cancer staging. Surgical intervention, along with chemotherapy or radiation therapy, is the mainstay of treatment. Currently, precision medicine has led to pe...
Autores principales: | Kuo, Chia-Yu, Moi, Sin-Hua, Hou, Ming-Feng, Luo, Chi-Wen, Pan, Mei-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10055970/ https://www.ncbi.nlm.nih.gov/pubmed/36982660 http://dx.doi.org/10.3390/ijms24065583 |
Ejemplares similares
-
Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer
por: Wang, Hui-Ching, et al.
Publicado: (2022) -
The Current Therapeutic Role of Chromatin Remodeling for the Prognosis and Treatment of Heart Failure
por: Kraus, Lindsay, et al.
Publicado: (2023) -
SWI/SNF Chromatin Remodeling Enzymes in Melanoma
por: Dreier, Megan R., et al.
Publicado: (2022) -
RNF8–CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
por: Kao, Chieh-Ni, et al.
Publicado: (2021) -
Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling Enzymes
por: Narlikar, Geeta J., et al.
Publicado: (2013)